Profile
John B III is listed in SEC filings as serving as a director for four public companies as of May 8, 2026: Orthofix Medical Inc., R1 RCM Inc. (NYSE: R1), Anika Therapeutics, Inc., and Aprea Therapeutics, Inc. The filings identify him solely by name without extended biographical details. No explicit background information (education, career history, or age) is provided in these filings. Based on the SEC context, he is a board director with governance responsibilities across medical devices, healthcare services, and biotech companies.
| Role | Insider |
|---|
| Notability | 25/100 |
|---|
Board memberships
- Orthofix Medical Inc.
- R1 RCM Inc.
- Anika Therapeutics, Inc.
- Aprea Therapeutics, Inc.
Awards & honors
- Public director across four U.S. listed healthcare companies as of 2026
- Experience in corporate governance and fiduciary oversight (inferred from board-director roles)
Frequently Asked Questions
Who is HENNEMAN JOHN B III?
John B III is listed in SEC filings as serving as a director for four public companies as of May 8, 2026: Orthofix Medical Inc., R1 RCM Inc. (NYSE: R1), Anika Therapeutics, Inc., and Aprea Therapeutics, Inc. The filings identify him solely by name without extended biographical details. No explicit background information (education, career history, or age) is provided in these f…
How many SEC Form 4 filings has HENNEMAN JOHN B III submitted recently?
5 primary Form 4 filings in the last 90 days, covering 3 companies.
Has HENNEMAN JOHN B III been buying or selling stock?
Recorded transactions: 2 open-market purchases ($135K) and 0 open-market sales () across all tracked filings.
Where can I see all of HENNEMAN JOHN B III's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.